IDEAYA Biosciences, Inc.
NASDAQ: IDYA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yujiro S. Hata
- Employees
- 131
- Headquarters
- South San Francisco, United States
- IPO year
- 2019
- Market cap
- $3.0B
- Website
- https://www.ideayabio.com
Loading IDYA…
Loading profile data…Frequently asked questions about IDYA
What does IDEAYA Biosciences, Inc. (IDYA) do?
IDEAYA Biosciences, Inc. is a precision oncology company primarily dedicated to identifying and advancing targeted therapies, particularly leveraging the concept of synthetic lethality. The firm aims to develop specific treatments for patient groups selected through molecular diagnostic methods. At the forefront of its clinical efforts are two i...
Where does IDYA trade?
IDEAYA Biosciences, Inc. (IDYA) trades on the NASDAQ Global Select.
What sector is IDYA in?
IDEAYA Biosciences, Inc. (IDYA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of IDEAYA Biosciences, Inc.?
Yujiro S. Hata is the chief executive officer of IDEAYA Biosciences, Inc. (IDYA).
Where is IDEAYA Biosciences, Inc. headquartered?
IDEAYA Biosciences, Inc. is headquartered in United States.
Does IDYA pay a dividend?
IDEAYA Biosciences, Inc. (IDYA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IDYA go public?
IDEAYA Biosciences, Inc. (IDYA) completed its initial public offering in 2019.